URGN logo

URGN
UroGen Pharma Ltd

2,283
Mkt Cap
$1.12B
Volume
836,114.00
52W High
$30.00
52W Low
$3.42
PE Ratio
-7.17
URGN Fundamentals
Price
$23.00
Prev Close
$23.83
Open
$23.65
50D MA
$20.40
Beta
1.06
Avg. Volume
772,253.02
EPS (Annual)
-$3.19
P/B
-10.54
Rev/Employee
$377,278.35
$1,135.16
Loading...
Loading...
News
all
press releases
Urogen Pharma (URGN) Projected to Post Quarterly Earnings on Wednesday
Urogen Pharma (NASDAQ:URGN) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-urogen-pharma-ltd-stock...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
IBRX: What Anktiva's Bladder Data Says About 2026 Sales
ImmunityBio heads into 2026 riding Anktiva growth, but upcoming bladder trial data and broader use in earlier care will be key to sustaining momentum.
Zacks·5d ago
News Placeholder
HC Wainwright Predicts Urogen Pharma Q1 Earnings
Urogen Pharma (NASDAQ:URGN - Free Report) - Stock analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for shares of Urogen Pharma in a report issued on Thursday, April...
MarketBeat·6d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Rating Increased to Strong-Buy at Jefferies Financial Group
Jefferies Financial Group raised Urogen Pharma to a "strong-buy" rating in a report on Friday...
MarketBeat·8d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Trading Up 9% - Should You Buy?
Urogen Pharma (NASDAQ:URGN) Trading 9% Higher - Here's Why...
MarketBeat·12d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Given Average Recommendation of "Moderate Buy" by Analysts
Urogen Pharma (NASDAQ:URGN - Get Free Report) has been given an average rating of "Moderate Buy" by the nine research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have given a buy rat...
MarketBeat·13d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Trading Down 4.5% - What's Next?
Urogen Pharma (NASDAQ:URGN) Shares Down 4.5% - Here's What Happened...
MarketBeat·19d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Shares Gap Up - Time to Buy?
Urogen Pharma (NASDAQ:URGN) Shares Gap Up - Still a Buy...
MarketBeat·22d ago
News Placeholder
Jefferies Financial Group Initiates Coverage on Urogen Pharma (NASDAQ:URGN)
Jefferies Financial Group began coverage on Urogen Pharma in a research note on Friday. They issued a "buy" rating and a $40.00 price objective on the stock...
MarketBeat·22d ago
News Placeholder
Urogen Pharma's (URGN) Buy Rating Reaffirmed at D. Boral Capital
D. Boral Capital reissued a "buy" rating and set a $33.00 price target on shares of Urogen Pharma in a report on Tuesday...
MarketBeat·1mo ago
<
1
2
...
>

Latest URGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.